Sustained Glycemic Outcomes with the MiniMed(™) 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years.
- DOI
- 10.1177/15209156261486558
- Published
- 2026 Sep 19
- Container
- Diabetes technology & therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/15209156261486558,
title = {Sustained Glycemic Outcomes with the MiniMed(™) 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years.},
author = {Castro M and Grassi B and Daín A and Gómez AM and Saleme A and Calliari LE and Siqueira R and Raggio M and Riera F and Sámano MAG and Liu M and Vigersky R and McVean J},
year = {2026},
journal = {Diabetes technology \& therapeutics},
doi = {10.1177/15209156261486558},
url = {https://doi.org/10.1177/15209156261486558}
}RIS
TY - JOUR TI - Sustained Glycemic Outcomes with the MiniMed(™) 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years. AU - Castro M AU - Grassi B AU - Daín A AU - Gómez AM AU - Saleme A AU - Calliari LE AU - Siqueira R AU - Raggio M AU - Riera F AU - Sámano MAG AU - Liu M AU - Vigersky R AU - McVean J PY - 2026 JO - Diabetes technology & therapeutics DO - 10.1177/15209156261486558 UR - https://doi.org/10.1177/15209156261486558 ER -
APA
M, C., B, G., A, D., AM, G., A, S., LE, C., R, S., M, R., F, R., MAG, S., M, L., R, V., & J, M. (2026). Sustained Glycemic Outcomes with the MiniMed(™) 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years.. Diabetes technology & therapeutics. https://doi.org/10.1177/15209156261486558
Source records
- pubmed · retrieved 2026-09-26T22:40:06.732Z